SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001714899-20-000075
Filing Date
2020-08-06
Accepted
2020-08-06 08:51:18
Documents
19
Period of Report
2020-08-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dnli-20200805.htm   iXBRL 8-K 81278
2 EX-99.1 ex991pressreleaseaugus.htm EX-99.1 32294
3 EX-99.2 ex992pressreleaseaugus.htm EX-99.2 18878
9 biogen-31.jpg GRAPHIC 11738
10 denalitlogo011.jpg GRAPHIC 65449
11 denalitlogo0111.jpg GRAPHIC 65449
  Complete submission text file 0001714899-20-000075.txt   488790

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dnli-20200805.xsd EX-101.SCH 2453
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dnli-20200805_cal.xml EX-101.CAL 730
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dnli-20200805_def.xml EX-101.DEF 1663
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dnli-20200805_lab.xml EX-101.LAB 23970
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dnli-20200805_pre.xml EX-101.PRE 12666
12 EXTRACTED XBRL INSTANCE DOCUMENT dnli-20200805_htm.xml XML 10822
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38311 | Film No.: 201080107
SIC: 2836 Biological Products, (No Diagnostic Substances)